Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10320602Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2026
Linked Award Amount
$1M
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#7,454
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Colleen Doyle Cooper as a PI. Multi-PI records show the full award amount for context.
- 5R44CA298512-02R44Development of CM-HZ01 as a non-alpha-IL2 therapeutic for the treatment of metastatic melanoma$1Maward amount
Award organization
Organizations that administered FY2026 awards listing Colleen Doyle Cooper as a PI.
FY2026 award administered by Celdara Medical, Llc (NH).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardCeldara Medical, Llc
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2026Entered Top 50% NationallyRanked #7454